LOGC

ContextLogic (LOGC)

ContextLogic Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LOGC

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/02/11	06:40	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:LOGC	ContextLogic Inc
2022/11/30	06:07	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:LOGC	ContextLogic Inc
2022/11/21	20:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06:05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06:05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06:04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06:04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06:04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:LOGC	ContextLogic Inc
2022/11/16	23:56	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:LOGC	ContextLogic Inc
2022/11/16	22:30	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:LOGC	ContextLogic Inc
2022/11/16	22:21	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:LOGC	ContextLogic Inc
2022/11/14	22:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:LOGC	ContextLogic Inc
2022/11/14	22:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/11/14	22:00	PR Newswire (US)	LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates	NASDAQ:LOGC	ContextLogic Inc
2022/10/20	21:55	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:LOGC	ContextLogic Inc
2022/10/19	05:14	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:LOGC	ContextLogic Inc
2022/10/19	05:04	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:LOGC	ContextLogic Inc
2022/10/14	05:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:LOGC	ContextLogic Inc
2022/10/08	05:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/10/04	05:47	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:LOGC	ContextLogic Inc
2022/10/04	00:20	Dow Jones News	LogicBio Therapeutics Shares Soar on Takeover by AstraZeneca	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	23:50	TipRanks	Analysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	21:19	TipRanks	AstraZeneca to Buy LogicBio Therapeutics for $2.07 Per Share	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20:57	Dow Jones News	AstraZeneca to Buy LogicBio Therapeutics for $68 Million	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20:15	Business Wire	Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20:00	PR Newswire (US)	Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine	NASDAQ:LOGC	ContextLogic Inc
2022/09/24	06:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/09/21	21:30	PR Newswire (US)	LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE	NASDAQ:LOGC	ContextLogic Inc
2022/09/21	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc